EXAI 5.22 (+3.78%)
US30223G1022BiotechnologyBiotechnology

Exscientia (EXAI) Stock Highlights

5.22 | +3.78%
2024-09-19 04:05:20
Exscientia PLC is an artificial intelligence-driven pharma tech company committed to discovering, designing, and developing drugs. Its patient-first AI process is comprised of Precision Target, Precision Design, Precision Experiment, and Precision Medicine. Its revenue is generated from Service fees related to drug discovery collaboration agreements it is utilizing its proprietary technology to develop novel Intellectual Property (IP); and Licensing fees related to drug discovery agreements.

Statistics

Range Today
5.08 5.55
Volume Today 1.02M
Range 1 Year
3.8 7.91
Volume 1 Year 165.15M
Range 3 Year
3.8 30.38
Volume 3 Year 285.09M
Range 10 Year
3.8 30.38
Volume 10 Year 285.09M

Highlights

Market Capitalization 638.9M (small)
Floating Shares 94.07M
Current Price 5.22
Price To Earnings -3.76
Price To Revenue 17.48
Price To Book 2.16
Earnings Per Share -1.35
Payout Ratio 0%

Performance

Latest +3.78%
1 Month -0.57%
3 Months +2.55%
6 Months -22.44%
1 Year +1.36%
3 Years -80.77%
5 Years -80.77%
10 Years -80.77%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.